Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Winfree KB"'
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 9, Pp 505-518 (2017)
Kaisa Taipale,1 Katherine B Winfree,2 Mark Boye,2 Mickael Basson,3 Ghassan Sleilaty,4 James Eaton,5 Rachel Evans,5 Christos Chouaid6 1Global Patient Outcomes and Real World Evidence International, Oy Eli Lilly Finland AB, Helsinki, Finland; 2Global P
Externí odkaz:
https://doaj.org/article/24525c4daeed46b4bb4c79c8bd6559f7
Publikováno v:
Cancer Management and Research, Vol 2014, Iss default, Pp 437-449 (2014)
Gebra Cuyún Carter,1 Amy M Barrett,2 James A Kaye,3 Astra M Liepa,1 Katherine B Winfree,1 William J John1 1Eli Lilly and Company, Indianapolis, IN, USA; 2RTI Health Solutions, Research Triangle Park, NC, USA; 3RTI Health Solutions, Waltham, MA, USA
Externí odkaz:
https://doaj.org/article/8dcb3fffd97b40a2b742f408a76d623b
Autor:
Winfree, KB1 (AUTHOR), Zhang, KH2 (AUTHOR), Muehlenbein, CE1 (AUTHOR), Panjic, EH1 (AUTHOR), Ale-Ali, A.1 (AUTHOR), Graham, CN2 (AUTHOR)
Publikováno v:
Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS143-S143. 1p.
Autor:
Pennell, NA, Clarke, JM, Liu, S, Gutierrez, M, Batus, M, Bauman, J, Fidler, MJ, Marmarelis, ME, Feliciano, J, Barzi, A, Lopes, G, Molife, C, Verma, S, Stefaniak, VJ, Winfree, KB, Belli, A, Cui, Z, Kim, S, Manion, C, Afolabi, M, Caria, N, Bonomi, P
Publikováno v:
In Value in Health July 2022 25(7) Supplement:S333-S333
Autor:
Bruno DS; University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, USA., Khanal M; Lilly Oncology, Eli Lilly and Company, Indianapolis, Indiana, USA., Li XI; Lilly Oncology, Eli Lilly and Company, Indianapolis, Indiana, USA., Escalon MP; Lilly Oncology, Eli Lilly and Company, Indianapolis, Indiana, USA., Winfree KB; Lilly Oncology, Eli Lilly and Company, Indianapolis, Indiana, USA., Hess LM; Lilly Oncology, Eli Lilly and Company, Indianapolis, Indiana, USA, hess_lisa_m@lilly.com.
Publikováno v:
Acta haematologica [Acta Haematol] 2024 May 20, pp. 1-15. Date of Electronic Publication: 2024 May 20.
Autor:
Molife C; Value, Evidence, and Outcomes-Oncology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. molife_cliff@lilly.com., Winfree KB; Value, Evidence, and Outcomes-Oncology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Bailey H; Adelphi Real World, Bollington, UK., D'yachkova Y; Statistics, Eli Lilly and Company, Vienna, Austria., Forshaw C; Adelphi Real World, Bollington, UK., Kim S; Global Patient Safety-Pharmacoepidemiology, Eli Lilly and Company, Indianapolis, IN, USA., Taipale KL; Value, Evidence, and Outcomes-International, Eli Lilly and Company, Helsinki, Finland., Puri T; Lilly International Medical Affairs Oncology, Eli Lilly and Company, Gurgaon, Haryana, India.
Publikováno v:
Advances in therapy [Adv Ther] 2023 Jul; Vol. 40 (7), pp. 3135-3168. Date of Electronic Publication: 2023 May 23.
Autor:
Aggarwal H; Eli Lilly & Company, 893 S Delaware Street Indianapolis, IN 46225, USA., Ndirangu K; ICON plc, New York, NY, USA., Winfree KB; Eli Lilly & Company, 893 S Delaware Street Indianapolis, IN 46225, USA., Muehlenbein CE; Eli Lilly & Company, 893 S Delaware Street Indianapolis, IN 46225, USA., Zhu E; Eli Lilly & Company, 893 S Delaware Street Indianapolis, IN 46225, USA., Tongbram V; ICON plc, New York, NY, USA., Thom H; Health Economics Bristol (HEB), Bristol Medical School, University of Bristol, 1-5 Whiteladies Road Clifton Bristol, BS8 1NU, United Kingdom.
Publikováno v:
Journal of comparative effectiveness research [J Comp Eff Res] 2023 Feb; Vol. 12 (2), pp. e220016. Date of Electronic Publication: 2023 Jan 09.
Autor:
Traore S; Eli Lilly and Company, Bracknell, UK., Sashegyi A; Eli Lilly and Company, Indianapolis, IN, USA., Winfree KB; Eli Lilly and Company, Indianapolis, IN, USA., Taipale KL; Oy Eli Lilly Finland Ab, Helsinki, Finland., Jen MH; Eli Lilly and Company, Bracknell, UK.
Publikováno v:
Journal of medical economics [J Med Econ] 2023 Jan-Dec; Vol. 26 (1), pp. 1479-1488. Date of Electronic Publication: 2023 Nov 30.
Autor:
Haeussler K; ICON plc, Munich, 81829, Germany., Wang X; ICON plc, Stockholm, 111 21, Sweden., Winfree KB; Eli Lilly & Company, Indianapolis, IN USA., D'yachkova Y; Eli Lilly GmbH, Vienna, Austria., Traore S; Eli Lilly & Company, Arlington Square, UK., Puri T; Eli Lilly & Company (India) Pvt Ltd, Gurgaon, India., Thom H; Bristol Medical School Population Health Sciences, University of Bristol, UK., Papagiannopoulos C; ICON plc, Stockholm, 111 21, Sweden., Nassim M; ICON plc, Munich, 81829, Germany., Taipale K; Oy Eli Lilly Finland Ab, Helsinki, Finland.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2022 May; Vol. 18 (16), pp. 2007-2028. Date of Electronic Publication: 2022 Feb 21.
Autor:
Winfree KB; Eli Lilly and Company, Indianapolis, IN, USA., Sheffield KM; Eli Lilly and Company, Indianapolis, IN, USA., Cui ZL; Eli Lilly and Company, Indianapolis, IN, USA., Sugihara T; Syneos Health, Morrisville, NC, USA., Feliciano J; Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2022 Jan; Vol. 38 (1), pp. 91-99. Date of Electronic Publication: 2021 Oct 12.